• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组Ad35腺病毒蛋白作为人类T细胞活化的有效调节剂。

Recombinant Ad35 adenoviral proteins as potent modulators of human T cell activation.

作者信息

Hay Joanne, Carter Darrick, Lieber André, Astier Anne L

机构信息

MRC Centre for Inflammation Research, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, EH16 4TJ, UK.

出版信息

Immunology. 2014 Sep 22;144(3):453-60. doi: 10.1111/imm.12391.

DOI:10.1111/imm.12391
PMID:25251258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4557682/
Abstract

The protein CD46 protects cells from complement attack by regulating cleavage of C3b and C3d. CD46 also regulates the adaptive immune response by controlling T cell activation and differentiation. Co-engagement of the T cell receptor and CD46 notably drives T cell differentiation by switching production of IFNγ to secretion of anti-inflammatory IL-10. This regulatory pathway is altered in several chronic inflammatory diseases highlighting its key role for immune homeostasis. The manipulation of the CD46 pathway may therefore provide a powerful means to regulate immune responses. Herein, we investigated the effect of recombinant proteins derived from the fiber knob of the adenovirus serotype 35 (Ad35) that uses CD46 as its entry receptor, on human T cell activation. We compared the effects of Ad35K++, engineered to exhibit enhanced affinity to CD46, and of Ad35K-, mutated in the binding site for CD46. Ad35K++ profoundly affects T cell activation by decreasing the levels of CD46 at the surface of primary T cells, and impairing T cell co-activation, shown by decreased CD25 expression, reduced proliferation and lower secretion of IL-10 and IFNγ. In contrast, Ad35K- acts a potent coactivator of T cells, enhancing T cell proliferation and cytokine production. These data show that recombinant Ad35 proteins are potent modulators of human T cell activation, and support their further development as potential drugs targeting T cell responses. This article is protected by copyright. All rights reserved.

摘要

蛋白质CD46通过调节C3b和C3d的裂解来保护细胞免受补体攻击。CD46还通过控制T细胞的激活和分化来调节适应性免疫反应。T细胞受体和CD46的共同参与显著地通过将IFNγ的产生转换为抗炎性IL-10的分泌来驱动T细胞分化。这条调节途径在几种慢性炎症性疾病中发生改变,突出了其对免疫稳态的关键作用。因此,对CD46途径的操控可能提供一种调节免疫反应的有力手段。在此,我们研究了源自腺病毒血清型35(Ad35)纤维结的重组蛋白对人T细胞激活的影响,Ad35以CD46作为其进入受体。我们比较了经工程改造以表现出对CD46增强亲和力的Ad35K++和在CD46结合位点发生突变的Ad35K-的作用。Ad35K++通过降低原代T细胞表面CD46的水平并损害T细胞共激活,从而深刻影响T细胞激活,这表现为CD25表达降低、增殖减少以及IL-10和IFNγ分泌减少。相比之下,Ad35K-作为T细胞的有效共激活剂,增强T细胞增殖和细胞因子产生。这些数据表明重组Ad35蛋白是人类T细胞激活的有效调节剂,并支持它们作为靶向T细胞反应的潜在药物的进一步开发。本文受版权保护。保留所有权利。

相似文献

1
Recombinant Ad35 adenoviral proteins as potent modulators of human T cell activation.重组Ad35腺病毒蛋白作为人类T细胞活化的有效调节剂。
Immunology. 2014 Sep 22;144(3):453-60. doi: 10.1111/imm.12391.
2
A recombinant adenovirus type 35 fiber knob protein sensitizes lymphoma cells to rituximab therapy.一种重组腺病毒 35 型纤维瘤 knob 蛋白使淋巴瘤细胞对利妥昔单抗治疗敏感。
Blood. 2010 Jan 21;115(3):592-600. doi: 10.1182/blood-2009-05-222463. Epub 2009 Nov 12.
3
Identification of CD46 binding sites within the adenovirus serotype 35 fiber knob.鉴定35型腺病毒纤维结内的CD46结合位点。
J Virol. 2007 Dec;81(23):12785-92. doi: 10.1128/JVI.01732-07. Epub 2007 Sep 26.
4
Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35.腺病毒血清型 35 载体诱导源自野生型和人 CD46 转基因小鼠的树突状细胞的固有免疫反应:与含有腺病毒血清型 35 纤维蛋白的纤维替代型 Ad 载体的比较。
J Control Release. 2010 Dec 1;148(2):212-8. doi: 10.1016/j.jconrel.2010.08.025. Epub 2010 Aug 26.
5
Downregulation of human CD46 by adenovirus serotype 35 vectors.35型腺病毒载体对人CD46的下调作用。
Gene Ther. 2007 Jun;14(11):912-9. doi: 10.1038/sj.gt.3302946. Epub 2007 Mar 22.
6
Monocyte:T-cell interaction regulates human T-cell activation through a CD28/CD46 crosstalk.单核细胞与T细胞的相互作用通过CD28/CD46串扰调节人类T细胞活化。
Immunol Cell Biol. 2015 Oct;93(9):796-803. doi: 10.1038/icb.2015.42. Epub 2015 Mar 19.
7
Localization of regions in CD46 that interact with adenovirus.CD46中与腺病毒相互作用区域的定位。
J Virol. 2005 Jun;79(12):7503-13. doi: 10.1128/JVI.79.12.7503-7513.2005.
8
Attenuation of CD4+ T-cell function by human adenovirus type 35 is mediated by the knob protein.人腺病毒 35 型通过 knob 蛋白抑制 CD4+T 细胞功能。
J Gen Virol. 2012 Jun;93(Pt 6):1339-1344. doi: 10.1099/vir.0.039222-0. Epub 2012 Feb 22.
9
The distal short consensus repeats 1 and 2 of the membrane cofactor protein CD46 and their distance from the cell membrane determine productive entry of species B adenovirus serotype 35.膜辅因子蛋白CD46的远端短共有重复序列1和2及其与细胞膜的距离决定了B种35型腺病毒的有效进入。
J Virol. 2005 Aug;79(15):10013-22. doi: 10.1128/JVI.79.15.10013-10022.2005.
10
Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation.腺病毒 35 型载体通过与 CD46 的结合阻断人 CD4+T 细胞的激活。
Proc Natl Acad Sci U S A. 2011 May 3;108(18):7499-504. doi: 10.1073/pnas.1017146108. Epub 2011 Apr 18.

引用本文的文献

1
CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells.CD46 和 CD59 抑制剂增强抗 CD38 单克隆抗体达雷妥尤单抗和伊沙妥昔单抗在多发性骨髓瘤和其他 B 细胞恶性肿瘤细胞中的补体依赖性细胞毒性。
Cancer Biol Ther. 2024 Dec 31;25(1):2314322. doi: 10.1080/15384047.2024.2314322. Epub 2024 Feb 15.
2
Designer Oncolytic Adenovirus: Coming of Age.设计型溶瘤腺病毒:走向成熟
Cancers (Basel). 2018 Jun 14;10(6):201. doi: 10.3390/cancers10060201.
3
Knob protein enhances epithelial barrier integrity and attenuates airway inflammation.旋钮蛋白增强上皮屏障完整性并减轻气道炎症。
J Allergy Clin Immunol. 2018 Dec;142(6):1808-1817.e3. doi: 10.1016/j.jaci.2018.01.049. Epub 2018 Mar 6.
4
Complement as a regulator of adaptive immunity.补体作为适应性免疫的调节剂。
Semin Immunopathol. 2018 Jan;40(1):37-48. doi: 10.1007/s00281-017-0644-y. Epub 2017 Aug 25.
5
Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic.Ad35K++ 蛋白的临床前安全性、药代动力学、药效学和生物分布研究:一种新型利妥昔单抗联合治疗药物。
Mol Ther Methods Clin Dev. 2016 Mar 30;5:16013. doi: 10.1038/mtm.2016.13. eCollection 2016.
6
Monocyte:T-cell interaction regulates human T-cell activation through a CD28/CD46 crosstalk.单核细胞与T细胞的相互作用通过CD28/CD46串扰调节人类T细胞活化。
Immunol Cell Biol. 2015 Oct;93(9):796-803. doi: 10.1038/icb.2015.42. Epub 2015 Mar 19.

本文引用的文献

1
Protein engineering to target complement evasion in cancer.靶向肿瘤逃避补体的蛋白质工程。
FEBS Lett. 2014 Jan 21;588(2):334-40. doi: 10.1016/j.febslet.2013.11.007. Epub 2013 Nov 14.
2
Transient removal of CD46 is safe and increases B-cell depletion by rituximab in CD46 transgenic mice and macaques.CD46 瞬时去除在 CD46 转基因小鼠和猕猴中是安全的,并增加了利妥昔单抗对 B 细胞的耗竭作用。
Mol Ther. 2013 Feb;21(2):291-9. doi: 10.1038/mt.2012.212. Epub 2012 Oct 23.
3
Attenuation of CD4+ T-cell function by human adenovirus type 35 is mediated by the knob protein.人腺病毒 35 型通过 knob 蛋白抑制 CD4+T 细胞功能。
J Gen Virol. 2012 Jun;93(Pt 6):1339-1344. doi: 10.1099/vir.0.039222-0. Epub 2012 Feb 22.
4
Complement in cancer and cancer immunotherapy.补体在癌症和癌症免疫治疗中的作用。
Arch Immunol Ther Exp (Warsz). 2011 Dec;59(6):407-19. doi: 10.1007/s00005-011-0146-x. Epub 2011 Sep 30.
5
CD46 processing: a means of expression.CD46 加工:一种表达手段。
Immunobiology. 2012 Feb;217(2):169-75. doi: 10.1016/j.imbio.2011.06.003. Epub 2011 Jul 13.
6
Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation.腺病毒 35 型载体通过与 CD46 的结合阻断人 CD4+T 细胞的激活。
Proc Natl Acad Sci U S A. 2011 May 3;108(18):7499-504. doi: 10.1073/pnas.1017146108. Epub 2011 Apr 18.
7
Ligation of CD46 to CD40 inhibits CD40 signaling in B cells.CD46 与 CD40 的结合抑制 B 细胞中 CD40 信号通路。
Int Immunol. 2011 Mar;23(3):215-21. doi: 10.1093/intimm/dxq474.
8
The dynamic processing of CD46 intracellular domains provides a molecular rheostat for T cell activation.CD46 细胞内结构域的动态处理为 T 细胞激活提供了分子变阻器。
PLoS One. 2011 Jan 19;6(1):e16287. doi: 10.1371/journal.pone.0016287.
9
Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens.CD46 细胞外部分的结构为其与补体蛋白和病原体的相互作用提供了线索。
PLoS Pathog. 2010 Sep 30;6(9):e1001122. doi: 10.1371/journal.ppat.1001122.
10
Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.siRNA 抑制膜补体抑制剂表达(CD46、CD55、CD59)可使肿瘤细胞在体外对补体攻击敏感。
Curr Cancer Drug Targets. 2010 Dec;10(8):922-31. doi: 10.2174/156800910793357952.